human bcma fc chimera protein (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
human bcma fc chimera protein
Human Bcma Fc Chimera Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bcma+fc+chimera+protein/Recombinant+Human+BCMA%2FTNFRSF17+Fc+Chimera+Protein%2C+CF/pmc12229333__41467_2025_60980_MOESM1_ESM-55-33-37
Average 93 stars, based on 9 article reviews
Human Bcma Fc Chimera Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bcma+fc+chimera+protein/Recombinant+Human+BCMA%2FTNFRSF17+Fc+Chimera+Protein%2C+CF/pmc12229333__41467_2025_60980_MOESM1_ESM-55-33-37
Average 93 stars, based on 9 article reviews
human bcma fc chimera protein - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Expressing:Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 10 6 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β. Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 106 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Compositions and methods for treating cancer with anti-BCMA immunotherapy Article Snippet: .. Flow Cytometry Staining To assess the cell surface expression of BCMA CARs, 0.5-1e6 CAR T-cells were resuspended in FACs buffer (Miltenyi Biotec's autoMACS Rinsing Solution+MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant FACS:Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 10 6 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β. Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 106 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Magnetic Cell Separation:Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 10 6 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β. Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 106 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Incubation:Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 10 6 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β. Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 106 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Compositions and methods for treating cancer with anti-BCMA immunotherapy Article Snippet: .. Flow Cytometry Staining To assess the cell surface expression of BCMA CARs, 0.5-1e6 CAR T-cells were resuspended in FACs buffer (Miltenyi Biotec's autoMACS Rinsing Solution+MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Article Snippet: .. 2 Flow Cytometry For the in vitro experiments using CAR T cells generated in-house, cells were washed with staining buffer (autoMACS® Rinsing Solution with 0.5% BSA) and incubated with 0.2 μg of recombinant Recombinant:Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 10 6 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β. Article Snippet: .. To assess the cell surface expression of BCMA CARs, 0.5 – 1 x 106 CAR T-cells were resuspended in FACS buffer (Miltenyi Biotec’s AutoMACS Rinsing Solution + MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Compositions and methods for treating cancer with anti-BCMA immunotherapy Article Snippet: .. Flow Cytometry Staining To assess the cell surface expression of BCMA CARs, 0.5-1e6 CAR T-cells were resuspended in FACs buffer (Miltenyi Biotec's autoMACS Rinsing Solution+MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Article Snippet: .. 2 Flow Cytometry For the in vitro experiments using CAR T cells generated in-house, cells were washed with staining buffer (autoMACS® Rinsing Solution with 0.5% BSA) and incubated with 0.2 μg of recombinant Flow Cytometry:Article Title: Compositions and methods for treating cancer with anti-BCMA immunotherapy Article Snippet: .. Flow Cytometry Staining To assess the cell surface expression of BCMA CARs, 0.5-1e6 CAR T-cells were resuspended in FACs buffer (Miltenyi Biotec's autoMACS Rinsing Solution+MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Article Snippet: .. 2 Flow Cytometry For the in vitro experiments using CAR T cells generated in-house, cells were washed with staining buffer (autoMACS® Rinsing Solution with 0.5% BSA) and incubated with 0.2 μg of recombinant Staining:Article Title: Compositions and methods for treating cancer with anti-BCMA immunotherapy Article Snippet: .. Flow Cytometry Staining To assess the cell surface expression of BCMA CARs, 0.5-1e6 CAR T-cells were resuspended in FACs buffer (Miltenyi Biotec's autoMACS Rinsing Solution+MACS BSA Stock Solution) and incubated with 0.5 ug of recombinant Article Title: Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Article Snippet: .. 2 Flow Cytometry For the in vitro experiments using CAR T cells generated in-house, cells were washed with staining buffer (autoMACS® Rinsing Solution with 0.5% BSA) and incubated with 0.2 μg of recombinant In Vitro:Article Title: Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Article Snippet: .. 2 Flow Cytometry For the in vitro experiments using CAR T cells generated in-house, cells were washed with staining buffer (autoMACS® Rinsing Solution with 0.5% BSA) and incubated with 0.2 μg of recombinant Generated:Article Title: Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Article Snippet: .. 2 Flow Cytometry For the in vitro experiments using CAR T cells generated in-house, cells were washed with staining buffer (autoMACS® Rinsing Solution with 0.5% BSA) and incubated with 0.2 μg of recombinant |
